Annual CFI
-$16.09 M
-$25.77 M-266.02%
December 31, 2024
Summary
- As of March 12, 2025, SLDB annual cash flow from investing activities is -$16.09 million, with the most recent change of -$25.77 million (-266.02%) on December 31, 2024.
- During the last 3 years, SLDB annual CFI has risen by +$75.00 million (+82.34%).
- SLDB annual CFI is now -127.19% below its all-time high of $59.16 million, reached on December 31, 2022.
Performance
SLDB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$38.57 M
+$49.55 M+451.02%
December 31, 2024
Summary
- As of March 12, 2025, SLDB quarterly cash flow from investing activities is $38.57 million, with the most recent change of +$49.55 million (+451.02%) on December 31, 2024.
- Over the past year, SLDB quarterly CFI has stayed the same.
- SLDB quarterly CFI is now -41.65% below its all-time high of $66.10 million, reached on December 31, 2022.
Performance
SLDB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$16.09 M
-$6.73 M-71.91%
December 31, 2024
Summary
- As of March 12, 2025, SLDB TTM cash flow from investing activities is -$16.09 million, with the most recent change of -$6.73 million (-71.91%) on December 31, 2024.
- Over the past year, SLDB TTM CFI has stayed the same.
- SLDB TTM CFI is now -122.97% below its all-time high of $70.04 million, reached on June 30, 2023.
Performance
SLDB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SLDB Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -266.0% | 0.0% | 0.0% |
| 3 y3 years | +82.3% | +180.0% | -123.0% |
| 5 y5 years | -165.6% | +180.0% | -123.0% |
SLDB Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -127.2% | +82.3% | -41.6% | +164.7% | -123.0% | +82.3% |
| 5 y | 5-year | -127.2% | +82.3% | -41.6% | +153.2% | -123.0% | +86.7% |
| alltime | all time | -127.2% | +82.3% | -41.6% | +153.2% | -123.0% | +86.7% |
Solid Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$16.09 M(-266.0%) | $38.57 M(-451.0%) | -$16.09 M(+71.9%) |
| Sep 2024 | - | -$10.99 M(+112.3%) | -$9.36 M(-59.3%) |
| Jun 2024 | - | -$5.18 M(-86.6%) | -$23.00 M(-65.2%) |
| Mar 2024 | - | -$38.49 M(-185.0%) | -$66.06 M(-781.8%) |
| Dec 2023 | $9.69 M(-83.6%) | $45.30 M(-283.9%) | $9.69 M(-68.2%) |
| Sep 2023 | - | -$24.64 M(-48.9%) | $30.49 M(-56.5%) |
| Jun 2023 | - | -$48.23 M(-229.4%) | $70.04 M(+19.4%) |
| Mar 2023 | - | $37.26 M(-43.6%) | $58.67 M(-0.8%) |
| Dec 2022 | $59.16 M(-164.9%) | $66.10 M(+343.4%) | $59.16 M(+154.6%) |
| Sep 2022 | - | $14.91 M(-125.0%) | $23.23 M(-136.2%) |
| Jun 2022 | - | -$59.59 M(-257.9%) | -$64.19 M(+20.4%) |
| Mar 2022 | - | $37.74 M(+25.1%) | -$53.31 M(-41.5%) |
| Dec 2021 | -$91.09 M(-1480.1%) | $30.18 M(-141.6%) | -$91.09 M(-24.9%) |
| Sep 2021 | - | -$72.51 M(+48.8%) | -$121.32 M(+148.1%) |
| Jun 2021 | - | -$48.72 M(>+9900.0%) | -$48.89 M(<-9900.0%) |
| Mar 2021 | - | -$35.00 K(-41.7%) | $147.00 K(-97.8%) |
| Dec 2020 | $6.60 M | -$60.00 K(-25.0%) | $6.60 M(-30.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$80.00 K(-124.8%) | $9.52 M(-29.8%) |
| Jun 2020 | - | $322.00 K(-95.0%) | $13.56 M(-63.7%) |
| Mar 2020 | - | $6.42 M(+124.8%) | $37.38 M(+52.5%) |
| Dec 2019 | $24.52 M(-191.6%) | $2.85 M(-28.0%) | $24.52 M(+6075.3%) |
| Sep 2019 | - | $3.96 M(-83.6%) | $397.00 K(-108.0%) |
| Jun 2019 | - | $24.14 M(-474.6%) | -$4.96 M(-84.3%) |
| Mar 2019 | - | -$6.45 M(-69.7%) | -$31.60 M(+18.1%) |
| Dec 2018 | -$26.76 M(-356.1%) | -$21.26 M(+1422.1%) | -$26.76 M(+222.2%) |
| Sep 2018 | - | -$1.40 M(-43.9%) | -$8.31 M(-41.6%) |
| Jun 2018 | - | -$2.49 M(+54.6%) | -$14.23 M(-858.7%) |
| Mar 2018 | - | -$1.61 M(-42.6%) | $1.88 M(-82.1%) |
| Dec 2017 | $10.45 M(-357.8%) | -$2.81 M(-61.6%) | $10.45 M(-21.2%) |
| Sep 2017 | - | -$7.32 M(-153.8%) | $13.26 M(-35.6%) |
| Jun 2017 | - | $13.61 M(+95.5%) | $20.57 M(+195.5%) |
| Mar 2017 | - | $6.96 M | $6.96 M |
| Dec 2016 | -$4.05 M(-84.9%) | - | - |
| Dec 2015 | -$26.81 M | - | - |
FAQ
- What is Solid Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Solid Biosciences?
- What is Solid Biosciences annual CFI year-on-year change?
- What is Solid Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Solid Biosciences?
- What is Solid Biosciences quarterly CFI year-on-year change?
- What is Solid Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Solid Biosciences?
- What is Solid Biosciences TTM CFI year-on-year change?
What is Solid Biosciences annual cash flow from investing activities?
The current annual CFI of SLDB is -$16.09 M
What is the all time high annual CFI for Solid Biosciences?
Solid Biosciences all-time high annual cash flow from investing activities is $59.16 M
What is Solid Biosciences annual CFI year-on-year change?
Over the past year, SLDB annual cash flow from investing activities has changed by -$25.77 M (-266.02%)
What is Solid Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of SLDB is $38.57 M
What is the all time high quarterly CFI for Solid Biosciences?
Solid Biosciences all-time high quarterly cash flow from investing activities is $66.10 M
What is Solid Biosciences quarterly CFI year-on-year change?
Over the past year, SLDB quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Solid Biosciences TTM cash flow from investing activities?
The current TTM CFI of SLDB is -$16.09 M
What is the all time high TTM CFI for Solid Biosciences?
Solid Biosciences all-time high TTM cash flow from investing activities is $70.04 M
What is Solid Biosciences TTM CFI year-on-year change?
Over the past year, SLDB TTM cash flow from investing activities has changed by $0.00 (0.00%)